1. PRKCD as a potential therapeutic target for chronic obstructive pulmonary disease
   Siqi Li et al, 2022, International Immunopharmacology CrossRef
2. PM2.5-induced lung injury is attenuated in macrophage-specific NLRP3 deficient mice
   Rui Xiong et al, 2021, Ecotoxicology and Environmental Safety CrossRef
3. Elevated levels of IL-32 in cerebrospinal fluid of neuro-Behcet disease: Correlation with NLRP3 inflammasome
   Kamel Hamzaoui et al, 2022, Journal of Neuroimmunology CrossRef
4. Fine particulate matter exposure exacerbated nasal mucosal damage in allergic rhinitis mice via NLRP3 mediated pyroptosis
   Juan Li et al, 2021, Ecotoxicology and Environmental Safety CrossRef
5. Oral Hydroxychloroquine Mitigates Lipopolysaccharide-induced Lung Injury by Inhibiting Pyroptosis in Mice
   Rui Xiong et al, 2023, Current Molecular Pharmacology CrossRef
6. Comprehensive analysis of pyroptosis‐related gene signatures for glioblastoma immune microenvironment and target therapy
   Zeyu Wang et al, 2023, Cell Proliferation CrossRef
7. The Link Between Adenoids and Nasopharyngeal Carcinoma
   Du-Bois Asante et al, 2023, Tonsils and Adenoids CrossRef
8. Role of toll-like receptor-mediated pyroptosis in sepsis-induced cardiomyopathy
   Yixuan Fan et al, 2023, Biomedicine & Pharmacotherapy CrossRef
9. Attenuation of Lipopolysaccharide-induced Liver Injury by Bone Marrow Mesenchymal Stem Cells via Inhibiting the NLRP3 Inflammasome and Hepatocyte Pyroptosis
   Yunyu Yin et al, 2022, Current Stem Cell Research & Therapy CrossRef
10. Adenoid hypertrophy in children: a narrative review of pathogenesis and clinical relevance
    Artur Niedzielski et al, 2023, BMJ Paediatrics Open CrossRef
11. Enhancement of the Tumor Suppression Effect of High-dose Radiation by Low-dose Pre-radiation Through Inhibition of DNA Damage Repair and Increased Pyroptosis
    Xinfeng Wei et al, 2024, Dose-Response CrossRef